Skip to main content

Main menu

  • Home
  • Content
    • Current
      • JNMT Supplement
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine Technology
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine Technology

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Watch or Listen to JNMT Podcast
  • Visit SNMMI on Facebook
  • Join SNMMI on LinkedIn
  • Follow SNMMI on Twitter
  • Subscribe to JNMT RSS feeds
Research ArticleBrief Communication

68Ga-Pentixafor PET/CT Demonstrating In Vivo CXCR4 Receptor Overexpression in Rare Lung Malignancies: Correlation with Histologic and Histochemical Findings

Ankit Watts, Baljinder Singh, Harmandeep Singh, Harneet Kaur, Amanjit Bal, Mehak Vohra, Sunil K. Arora and D. Behera
Journal of Nuclear Medicine Technology September 2022, 50 (3) 278-281; DOI: https://doi.org/10.2967/jnmt.122.264141
Ankit Watts
1Department of Nuclear Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Baljinder Singh
1Department of Nuclear Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Harmandeep Singh
1Department of Nuclear Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Harneet Kaur
1Department of Nuclear Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amanjit Bal
2Department of Histopathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mehak Vohra
3Department of Immunopathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sunil K. Arora
3Department of Immunopathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D. Behera
4Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 50 no. 3 278-281
DOI 
https://doi.org/10.2967/jnmt.122.264141
PubMed 
35610039

Published By 
Society of Nuclear Medicine
Print ISSN 
0091-4916
Online ISSN 
1535-5675
History 
  • Received for publication March 22, 2022
  • Accepted for publication April 27, 2022
  • Published online September 8, 2022.

Article Versions

  • previous version (May 24, 2022 - 14:10).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2022 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

  1. Ankit Watts1,
  2. Baljinder Singh1,
  3. Harmandeep Singh1,
  4. Harneet Kaur1,
  5. Amanjit Bal2,
  6. Mehak Vohra3,
  7. Sunil K. Arora3 and
  8. D. Behera4
  1. 1Department of Nuclear Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India;
  2. 2Department of Histopathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India;
  3. 3Department of Immunopathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India; and
  4. 4Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India
  1. For correspondence or reprints, contact Baljinder Singh (drbsingh5144{at}yahoo.com).
View Full Text

Statistics from Altmetric.com

Cited By...

  • 3 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • 68Ga-Pentixafor PET/CT for In Vivo Imaging of CXCR4 Receptors in Glioma Demonstrating a Potential for Response Assessment to Radiochemotherapy: Preliminary Results
    Abdul Waheed, Baljinder Singh, Ankit Watts, Harneet Kaur, Harmandeep Singh, Kirti Dhingra, Chirag Ahuja, Renu Madan, Apinderpreet Singh, Bishan D. Radotra
    Clinical Nuclear Medicine 2024 49 4
  • India's Growing Nuclear Medicine Infrastructure and Emergence of Radiotheranostics in Cancer Care: Associated Challenges and the Opportunities to Collaborate
    Baljinder Singh, Ghanshyam Sahani, Vikas Prasad, Ankit Watts, Rakesh Kumar
    Indian Journal of Nuclear Medicine 2023 38 3
  • 68Ga-Pentixafor PET/CT for in-vivo mapping of CXCR4 receptors as potential radiotheranostic targets in soft tissue and bone sarcoma: preliminary results
    Santosh Ranjan Jena, Ankit Watts, Piyush Aggarwal, Vikas Bachhal, Harneet Kaur, Kirti Dhingra, Harmandeep Singh, Amanjit Bal, Baljinder Singh
    Nuclear Medicine Communications 2024 45 3

Article usage

Article usage: May 2022 to April 2025

AbstractFullPdf
May 202222102
Jun 202239106
Jul 202213003
Aug 202214702
Sep 202237010
Oct 202235456
Nov 202232911
Dec 202218732
Jan 202319244
Feb 202311501
Mar 202310300
Apr 20235300
May 20236522
Jun 20236238
Jul 20235908
Aug 20234437
Sep 202315711
Oct 2023162015
Nov 2023162222
Dec 2023153635
Jan 2024163014
Feb 2024171213
Mar 2024101528
Apr 2024144129
May 202477726
Jun 2024205325
Jul 2024162225
Aug 2024133129
Sep 2024253636
Oct 2024184846
Nov 2024224219
Dec 2024145118
Jan 202592613
Feb 2025147719
Mar 2025258839
Apr 2025185945
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine Technology: 50 (3)
Journal of Nuclear Medicine Technology
Vol. 50, Issue 3
September 1, 2022
  • Table of Contents
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
68Ga-Pentixafor PET/CT Demonstrating In Vivo CXCR4 Receptor Overexpression in Rare Lung Malignancies: Correlation with Histologic and Histochemical Findings
(Your Name) has sent you a message from Journal of Nuclear Medicine Technology
(Your Name) thought you would like to see the Journal of Nuclear Medicine Technology web site.
Citation Tools
68Ga-Pentixafor PET/CT Demonstrating In Vivo CXCR4 Receptor Overexpression in Rare Lung Malignancies: Correlation with Histologic and Histochemical Findings
Ankit Watts, Baljinder Singh, Harmandeep Singh, Harneet Kaur, Amanjit Bal, Mehak Vohra, Sunil K. Arora, D. Behera
Journal of Nuclear Medicine Technology Sep 2022, 50 (3) 278-281; DOI: 10.2967/jnmt.122.264141

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
68Ga-Pentixafor PET/CT Demonstrating In Vivo CXCR4 Receptor Overexpression in Rare Lung Malignancies: Correlation with Histologic and Histochemical Findings
Ankit Watts, Baljinder Singh, Harmandeep Singh, Harneet Kaur, Amanjit Bal, Mehak Vohra, Sunil K. Arora, D. Behera
Journal of Nuclear Medicine Technology Sep 2022, 50 (3) 278-281; DOI: 10.2967/jnmt.122.264141
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Visual Abstract
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Patient Motion During Cardiac PET Imaging
  • Fitness for Purpose of Text-to-Image Generative Artificial Intelligence Image Creation in Medical Imaging
  • Logistics of Adopting 177Lu-Vipivotide Tetraxetan Therapy in a Community-Based Hospital Setting
Show more Brief Communication

Similar Articles

Keywords

  • [68Ga]pentixafor
  • PET/CT imaging
  • CXCR4 receptors
  • lung cancer
  • rare variants
  • metastasis
SNMMI

© 2025 SNMMI

Powered by HighWire